Supplements
Wild oregano oil scores low on effectiveness due to scant high-quality human evidence—small open studies show promise for topical fungal infections and SIBO in herbal blends (e.g., 46% eradication rate vs rifaximin's 34% in n=104 trial), but no robust RCTs confirm oral benefits for common claims like immune boosting. In vitro data supports carvacrol's antimicrobial action, but clinical translation is weak. Safety is solid (GRAS, no liver cases), docking points for GI risks and pregnancy contrain
Wild oregano oil shows limited promise as a short-term antimicrobial aid based on small studies for SIBO and fungal issues, but lacks robust evidence for general supplement use. Opt for standardized, tested brands if trying. Consult a doctor due to side effects and interactions.